United States (US) Stomach Cancer Treatment Market (2025-2031) | Trends, Forecast, Outlook, Companies, Segmentation, Share, Competitive Landscape, Analysis, Value, Size & Revenue, Growth, Industry

Name: United States (US) Stomach Cancer Treatment Market (2025-2031) | Trends & Forecast
Creator: 6Wresearch
License: https://www.6wresearch.com/privacy-policy

Market Forecast By Treatment Type (Immunotherapy, Targeted Therapy, Chemotherapy, Radiation Therapy And Surgery (Qualitative Analysis Only)), By Disease Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Route of Administration (Oral, Injectable), By Drug Class (PD-1/PD-L1 Inhibitors, HER2 Antagonists, VEGFR2 Antagonists, Others), By Distribution Channel (Hospital Pharmacies, Specialty & Retail Pharmacies, Others) And Competitive Landscape

Product Code: ETC9977239	Publication Date: Sep 2024	Updated Date: Aug 2025	Product Type: Market Research Report
Publisher: 6Wresearch	Author: Summon Dutta	No. of Pages: 75	No. of Figures: 35	No. of Tables: 20

Key Highlights of the Report:

United States (US) Stomach Cancer Treatment Market Outlook
Market Size of United States (US) Stomach Cancer Treatment Market, 2024
Forecast of United States (US) Stomach Cancer Treatment Market, 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Revenues & Volume for the Period 2021- 2031
United States (US) Stomach Cancer Treatment Market Trend Evolution
United States (US) Stomach Cancer Treatment Market Drivers and Challenges
United States (US) Stomach Cancer Treatment Price Trends
United States (US) Stomach Cancer Treatment Porter's Five Forces
United States (US) Stomach Cancer Treatment Industry Life Cycle
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Treatment Type for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Immunotherapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Targeted Therapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Chemotherapy for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Radiation Therapy And Surgery (Qualitative Analysis Only) for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Disease Indication for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Gastric Cancer/Gastroesophageal Junction Cancer for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Gastrointestinal Stromal Tumors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Route of Administration for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Oral for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Injectable for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Drug Class for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By PD-1/PD-L1 Inhibitors for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By HER2 Antagonists for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By VEGFR2 Antagonists for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Others for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Specialty & Retail Pharmacies for the Period 2021- 2031
Historical Data and Forecast of United States (US) Stomach Cancer Treatment Market Revenues & Volume By Others for the Period 2021- 2031
United States (US) Stomach Cancer Treatment Import Export Trade Statistics
Market Opportunity Assessment By Treatment Type
Market Opportunity Assessment By Disease Indication
Market Opportunity Assessment By Route of Administration
Market Opportunity Assessment By Drug Class
Market Opportunity Assessment By Distribution Channel
United States (US) Stomach Cancer Treatment Top Companies Market Share
United States (US) Stomach Cancer Treatment Competitive Benchmarking By Technical and Operational Parameters
United States (US) Stomach Cancer Treatment Company Profiles
United States (US) Stomach Cancer Treatment Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

How does 6Wresearch market report help businesses in making strategic decisions?

Do you also provide customisation in the market study?

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Stomach Cancer Treatment Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Stomach Cancer Treatment Market - Industry Life Cycle

3.4 United States (US) Stomach Cancer Treatment Market - Porter's Five Forces

3.5 United States (US) Stomach Cancer Treatment Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F

3.6 United States (US) Stomach Cancer Treatment Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F

3.7 United States (US) Stomach Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United States (US) Stomach Cancer Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.9 United States (US) Stomach Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

4 United States (US) Stomach Cancer Treatment Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence and prevalence of stomach cancer in the United States

4.2.2 Technological advancements in stomach cancer treatment options

4.2.3 Growing awareness about early detection and treatment of stomach cancer

4.3 Market Restraints

4.3.1 High cost associated with stomach cancer treatments

4.3.2 Stringent regulatory requirements for approval of new treatment options

4.3.3 Limited access to specialized healthcare facilities in certain regions of the United States

5 United States (US) Stomach Cancer Treatment Market Trends

6 United States (US) Stomach Cancer Treatment Market, By Types

6.1 United States (US) Stomach Cancer Treatment Market, By Treatment Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Treatment Type, 2021- 2031F

6.1.3 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F

6.1.4 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.5 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.1.6 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Radiation Therapy And Surgery (Qualitative Analysis Only), 2021- 2031F

6.2 United States (US) Stomach Cancer Treatment Market, By Disease Indication

6.2.1 Overview and Analysis

6.2.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Gastric Cancer/Gastroesophageal Junction Cancer, 2021- 2031F

6.2.3 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021- 2031F

6.3 United States (US) Stomach Cancer Treatment Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Injectable, 2021- 2031F

6.4 United States (US) Stomach Cancer Treatment Market, By Drug Class

6.4.1 Overview and Analysis

6.4.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By PD-1/PD-L1 Inhibitors, 2021- 2031F

6.4.3 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By HER2 Antagonists, 2021- 2031F

6.4.4 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By VEGFR2 Antagonists, 2021- 2031F

6.4.5 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F

6.5 United States (US) Stomach Cancer Treatment Market, By Distribution Channel

6.5.1 Overview and Analysis

6.5.2 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.5.3 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Specialty & Retail Pharmacies, 2021- 2031F

6.5.4 United States (US) Stomach Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F

7 United States (US) Stomach Cancer Treatment Market Import-Export Trade Statistics

7.1 United States (US) Stomach Cancer Treatment Market Export to Major Countries

7.2 United States (US) Stomach Cancer Treatment Market Imports from Major Countries

8 United States (US) Stomach Cancer Treatment Market Key Performance Indicators

8.1 Survival rate of stomach cancer patients in the United States

8.2 Adoption rate of minimally invasive surgical techniques for stomach cancer treatment

8.3 Number of clinical trials and research studies focused on stomach cancer treatments in the United States

9 United States (US) Stomach Cancer Treatment Market - Opportunity Assessment

9.1 United States (US) Stomach Cancer Treatment Market Opportunity Assessment, By Treatment Type, 2021 & 2031F

9.2 United States (US) Stomach Cancer Treatment Market Opportunity Assessment, By Disease Indication, 2021 & 2031F

9.3 United States (US) Stomach Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United States (US) Stomach Cancer Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.5 United States (US) Stomach Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

10 United States (US) Stomach Cancer Treatment Market - Competitive Landscape

10.1 United States (US) Stomach Cancer Treatment Market Revenue Share, By Companies, 2024

10.2 United States (US) Stomach Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Africa Stomach Cancer Treatment Market

Equatorial Guinea Stomach Cancer Treatment Market

Eritrea Stomach Cancer Treatment Market

Estonia Stomach Cancer Treatment Market

Fiji Stomach Cancer Treatment Market

Finland Stomach Cancer Treatment Market

Global Stomach Cancer Treatment Market

Middle East Stomach Cancer Treatment Market

North America Stomach Cancer Treatment Market

Global Go To Market Strategy - 2030

Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.

By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.

To discover high-growth global markets and optimize your business strategy:

Click Here